Skip Navigation



Hum. Reprod. Advance Access published online on March 10, 2008

Human Reproduction, doi:10.1093/humrep/den044
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
23/5/1053    most recent
den044v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Finas, D.
Right arrow Articles by Hornung, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finas, D.
Right arrow Articles by Hornung, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

L1 cell adhesion molecule (L1CAM) as a pathogenetic factor in endometriosis

D. Finas1,{dagger}, M. Huszar2,{dagger}, A. Agic1, S. Dogan1, H. Kiefel3, S. Riedle3, D. Gast3, R. Marcovich2, F. Noack4, P. Altevogt3, M. Fogel2 and D. Hornung1,5

1 Department of Obstetrics and Gynecology, University of Schleswig-Holstein, Ratzeburgerallee 160, 23538 Luebeck, Germany 2 Department of Pathology, Kaplan Medical Center, 76100 Rehovot, Israel 3 Tumorimmunology Programme, D010, German Cancer Research Center, 69120 Heidelberg, Germany 4 Department of Pathology, University of Schleswig-Holstein, 23538 Luebeck, Germany

5 Correspondence address. Tel: +49-451-500-0; Fax: +49-451-500-2139; E-mail: d.hornung{at}gmx.de

BACKGROUND: Endometriosis is a benign and progressive disease with a high prevalence. Women with endometriosis, especially with atypical endometriosis, have a higher probability for developing ovarian cancer compared with women without endometriosis. The L1 cell adhesion molecule (L1CAM) is over expressed in ovarian and endometrial carcinomas and is associated with a bad prognosis. Here, we have analysed L1CAM expression in endometriosis.

METHODS AND RESULTS: In our study with the samples from 79 patients with, and 37 patients without, endometriosis, we found that endometriosis cell lines and short-term cultures of endometrium from women with endometriosis expressed L1CAM at the mRNA and protein level. Quantitative RT-PCR analysis showed that L1CAM was expressed at significantly higher level in the epithelial compartment from patients with endometriosis compared with healthy controls (P = 0.0126). By immunohistochemical staining, 15 of 31 ovarian endometriotic lesions (48%) were shown to have L1CAM-positive staining. Of these 15 L1CAM-positive samples, 13 were atypical endometriotic lesions. Soluble L1 present in the conditioned medium of epithelial endometrium cultures from women with endometriosis was able to stimulate neurite outgrowth as measured in a chicken ganglion assay.

CONCLUSIONS: We propose that L1CAM could promote endometriosis development by increasing enervation and aggravation. L1CAM expression is higher in atypical endometriosis compared with normal endometriosis.

Key words: atypical endometriosis/endometriosis/immunohistochemistry/L1CAM/quantitative RT-PCR


{dagger} Both authors contributed equally to this work.

Submitted on May 6, 2007; resubmitted on January 19, 2008; accepted on January 30, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.